Arndt Weinmann

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

Sarah Berhane, Hidenori Toyoda, Toshifumi Tada et al. · Clinical Gastroenterology and Hepatology · 2016 · 311 citations

Hepatology, Balad-2 Serologic Models, Medicine +8

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

Marianne Sinn, Marcus Bahra, Torsten Liersch et al. · Journal of Clinical Oncology · 2017 · 291 citations

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein et al. · Journal of Hepatology · 2021 · 284 citations · Full text

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

Jan Best, Lars P. Bechmann, Jan‐Peter Sowa et al. · Clinical Gastroenterology and Hepatology · 2019 · 277 citations